Caspase-cleaved amyloid precursor protein and activated caspase-3 are co-localized in the granules of granulovacuolar degeneration in Alzheimer's disease and Down's syndrome brain

Acta Neuropathol. 2002 Jul;104(1):1-6. doi: 10.1007/s00401-002-0548-2. Epub 2002 May 9.

Abstract

Granulovacuolar degeneration (GVD) is a diagnostic neuropathological feature of Alzheimer's disease (AD). In some neurons, apoptosis has been hypothesized to be a primary mechanism causing neuronal cell death in AD. In this study we investigated CA1 neurons with GVD in AD and Down's syndrome (DS) brain. We demonstrated that activated caspase-3 and a caspase-cleaved cleavage product of the amyloid precursor protein (cAPP) are co-localized in GVD granules, and that these same cells often show nuclear DNA damage. In contrast, activated caspase-8 is present in the cytoplasm but not within the granules of GVD neurons. A caspase-cleavage product of fodrin that accumulates in many AD and DS neurons is not present in GVD granules. These data support a role for the activation of apoptotic mechanisms in selective compartments exhibiting GVD.

MeSH terms

  • Aged
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / pathology*
  • Amyloid beta-Protein Precursor / metabolism*
  • Brain / metabolism
  • Brain / pathology*
  • Caspase 3
  • Caspase 8
  • Caspase 9
  • Caspases / metabolism*
  • Cytoplasm / metabolism
  • Cytoplasm / pathology
  • Down Syndrome / metabolism
  • Down Syndrome / pathology*
  • Humans
  • Immunohistochemistry
  • Neurons / metabolism
  • Neurons / pathology
  • Vacuoles / metabolism
  • Vacuoles / pathology

Substances

  • Amyloid beta-Protein Precursor
  • CASP3 protein, human
  • CASP8 protein, human
  • CASP9 protein, human
  • Caspase 3
  • Caspase 8
  • Caspase 9
  • Caspases